Sign In

Robert Tansley

Life Sciences investor and biotech executive

Robert Tansley is a Board Member at T-Therapeutics Ltd and a partner at Cambridge Innovation Capital (CIC). Here are some key details about him:

Professional Background

Robert Tansley is a partner at Cambridge Innovation Capital, focusing on life sciences investments.4 He joined T-Therapeutics' Board of Directors following CIC's investment in the company's £48 million Series A funding round.12

Experience and Expertise

  • Robert has over a decade of experience in early-stage biotech companies.3
  • He has held leadership positions such as Chief Medical Officer at Arakis, founder and CEO at Treague, founding CEO of Avilex Pharma, and founding Chief Medical Officer of KalVista.3

Education and Qualifications

  • Qualified in medicine from UCL
  • Member of the Royal College of Obstetricians & Gynaecologists
  • Member of the Faculty of Pharmaceutical Medicine
  • MBA from London Business School
  • M.Phil in Biostatistics from the University of Cambridge3

Investment Portfolio

At CIC, Robert manages investments in several companies, including:

  • Carrick Therapeutics
  • CMR Surgical
  • Exvastat
  • Microbiotica
  • Pretzel Therapeutics
  • T-Therapeutics3

Robert Tansley's involvement with T-Therapeutics demonstrates his expertise in life sciences and his role in supporting innovative biotech companies developing novel therapeutics.

Highlights

Nov 14 · cic.vc
Cambridge Innovation Capital announces its investment in T ...

Related Questions

What is Robert Tansley's background before joining T-Therapeutics?
How has Robert Tansley contributed to Cambridge Innovation Capital's investments?
What other companies has Robert Tansley worked with?
What are Robert Tansley's main responsibilities at T-Therapeutics?
How does Robert Tansley's experience align with T-Therapeutics' mission?
Robert Tansley
Robert Tansley, photo 1
Robert Tansley, photo 2
Add to my network

Location

Greater Cambridge Area